NCT05226338View on ClinicalTrials.gov

Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

December 23, 2021

Study Completion Date

May 11, 2022

Conditions
Healthy Female Volunteer
Interventions
DRUG

D-0502

Formulation 1 Formulation 2 Formulation 3

Trial Locations (1)

32114

Labcorp Clinical Research Unit, Daytona Beach

Sponsors
All Listed Sponsors
lead

InventisBio Co., Ltd

INDUSTRY